世界の網膜色素変性症治療＆管理市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinitis Pigmentosa Treatment & Management Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5024 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、網膜色素変性症治療＆管理のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンA、ドコサヘキサエン酸、カルシウムチャネル遮断薬、遺伝子療法、網膜義眼）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・網膜色素変性症治療＆管理の市場動向 ・企業の競争状況、市場シェア ・網膜色素変性症治療＆管理の種類別市場規模（ビタミンA、ドコサヘキサエン酸、カルシウムチャネル遮断薬、遺伝子療法、網膜義眼） ・網膜色素変性症治療＆管理の用途別市場規模（病院、外来手術センター、その他） ・網膜色素変性症治療＆管理の北米市場規模2016-2027（アメリカ、カナダ） ・網膜色素変性症治療＆管理のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜色素変性症治療＆管理のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜色素変性症治療＆管理の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜色素変性症治療＆管理の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ReNeuron、Amarantus BioScience、Ocugen、ReGenX Biosciences、Sucampo Pharmaceuticals、Orphagen Pharmaceuticals、Okuvision、Second Sight Medical） ・結論

Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision.
Retinitis pigmentosa is generally inherited from a person’s parents. Mutations in one of more than 50 genes is involved.

Market Analysis and Insights: Global Retinitis Pigmentosa Treatment & Management Market
The global Retinitis Pigmentosa Treatment & Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinitis Pigmentosa Treatment & Management market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinitis Pigmentosa Treatment & Management market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinitis Pigmentosa Treatment & Management market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinitis Pigmentosa Treatment & Management market.

Global Retinitis Pigmentosa Treatment & Management Scope and Market Size
Retinitis Pigmentosa Treatment & Management market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinitis Pigmentosa Treatment & Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Vitamin A
Docosahexaenoic Acid
Calcium Channel Blockers
Gene Therapy
Retinal Eye Prosthetics

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
ReNeuron
Amarantus BioScience
Ocugen
ReGenX Biosciences
Sucampo Pharmaceuticals
Orphagen Pharmaceuticals
Okuvision
Second Sight Medical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vitamin A
1.2.3 Docosahexaenoic Acid
1.2.4 Calcium Channel Blockers
1.2.5 Gene Therapy
1.2.6 Retinal Eye Prosthetics
1.3 Market by Application
1.3.1 Global Retinitis Pigmentosa Treatment & Management Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinitis Pigmentosa Treatment & Management Market Perspective (2016-2027)
2.2 Retinitis Pigmentosa Treatment & Management Growth Trends by Regions
2.2.1 Retinitis Pigmentosa Treatment & Management Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinitis Pigmentosa Treatment & Management Historic Market Share by Regions (2016-2021)
2.2.3 Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Regions (2022-2027)
2.3 Retinitis Pigmentosa Treatment & Management Industry Dynamic
2.3.1 Retinitis Pigmentosa Treatment & Management Market Trends
2.3.2 Retinitis Pigmentosa Treatment & Management Market Drivers
2.3.3 Retinitis Pigmentosa Treatment & Management Market Challenges
2.3.4 Retinitis Pigmentosa Treatment & Management Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinitis Pigmentosa Treatment & Management Players by Revenue
3.1.1 Global Top Retinitis Pigmentosa Treatment & Management Players by Revenue (2016-2021)
3.1.2 Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Players (2016-2021)
3.2 Global Retinitis Pigmentosa Treatment & Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinitis Pigmentosa Treatment & Management Revenue
3.4 Global Retinitis Pigmentosa Treatment & Management Market Concentration Ratio
3.4.1 Global Retinitis Pigmentosa Treatment & Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa Treatment & Management Revenue in 2020
3.5 Retinitis Pigmentosa Treatment & Management Key Players Head office and Area Served
3.6 Key Players Retinitis Pigmentosa Treatment & Management Product Solution and Service
3.7 Date of Enter into Retinitis Pigmentosa Treatment & Management Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinitis Pigmentosa Treatment & Management Breakdown Data by Type
4.1 Global Retinitis Pigmentosa Treatment & Management Historic Market Size by Type (2016-2021)
4.2 Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Type (2022-2027)

5 Retinitis Pigmentosa Treatment & Management Breakdown Data by Application
5.1 Global Retinitis Pigmentosa Treatment & Management Historic Market Size by Application (2016-2021)
5.2 Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinitis Pigmentosa Treatment & Management Market Size (2016-2027)
6.2 North America Retinitis Pigmentosa Treatment & Management Market Size by Type
6.2.1 North America Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021)
6.2.2 North America Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027)
6.2.3 North America Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2027)
6.3 North America Retinitis Pigmentosa Treatment & Management Market Size by Application
6.3.1 North America Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021)
6.3.2 North America Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027)
6.3.3 North America Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2027)
6.4 North America Retinitis Pigmentosa Treatment & Management Market Size by Country
6.4.1 North America Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021)
6.4.2 North America Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Retinitis Pigmentosa Treatment & Management Market Size (2016-2027)
7.2 Europe Retinitis Pigmentosa Treatment & Management Market Size by Type
7.2.1 Europe Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021)
7.2.2 Europe Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027)
7.2.3 Europe Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2027)
7.3 Europe Retinitis Pigmentosa Treatment & Management Market Size by Application
7.3.1 Europe Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021)
7.3.2 Europe Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027)
7.3.3 Europe Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2027)
7.4 Europe Retinitis Pigmentosa Treatment & Management Market Size by Country
7.4.1 Europe Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021)
7.4.2 Europe Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size (2016-2027)
8.2 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Type
8.2.1 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Application
8.3.1 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Region
8.4.1 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinitis Pigmentosa Treatment & Management Market Size (2016-2027)
9.2 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Type
9.2.1 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021)
9.2.2 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027)
9.2.3 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2027)
9.3 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Application
9.3.1 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021)
9.3.2 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027)
9.3.3 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2027)
9.4 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Country
9.4.1 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021)
9.4.2 Latin America Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size (2016-2027)
10.2 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Type
10.2.1 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Application
10.3.1 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Country
10.4.1 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 ReNeuron
11.1.1 ReNeuron Company Details
11.1.2 ReNeuron Business Overview
11.1.3 ReNeuron Retinitis Pigmentosa Treatment & Management Introduction
11.1.4 ReNeuron Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.1.5 ReNeuron Recent Development
11.2 Amarantus BioScience
11.2.1 Amarantus BioScience Company Details
11.2.2 Amarantus BioScience Business Overview
11.2.3 Amarantus BioScience Retinitis Pigmentosa Treatment & Management Introduction
11.2.4 Amarantus BioScience Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.2.5 Amarantus BioScience Recent Development
11.3 Ocugen
11.3.1 Ocugen Company Details
11.3.2 Ocugen Business Overview
11.3.3 Ocugen Retinitis Pigmentosa Treatment & Management Introduction
11.3.4 Ocugen Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.3.5 Ocugen Recent Development
11.4 ReGenX Biosciences
11.4.1 ReGenX Biosciences Company Details
11.4.2 ReGenX Biosciences Business Overview
11.4.3 ReGenX Biosciences Retinitis Pigmentosa Treatment & Management Introduction
11.4.4 ReGenX Biosciences Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.4.5 ReGenX Biosciences Recent Development
11.5 Sucampo Pharmaceuticals
11.5.1 Sucampo Pharmaceuticals Company Details
11.5.2 Sucampo Pharmaceuticals Business Overview
11.5.3 Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management Introduction
11.5.4 Sucampo Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.5.5 Sucampo Pharmaceuticals Recent Development
11.6 Orphagen Pharmaceuticals
11.6.1 Orphagen Pharmaceuticals Company Details
11.6.2 Orphagen Pharmaceuticals Business Overview
11.6.3 Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management Introduction
11.6.4 Orphagen Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.6.5 Orphagen Pharmaceuticals Recent Development
11.7 Okuvision
11.7.1 Okuvision Company Details
11.7.2 Okuvision Business Overview
11.7.3 Okuvision Retinitis Pigmentosa Treatment & Management Introduction
11.7.4 Okuvision Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.7.5 Okuvision Recent Development
11.8 Second Sight Medical
11.8.1 Second Sight Medical Company Details
11.8.2 Second Sight Medical Business Overview
11.8.3 Second Sight Medical Retinitis Pigmentosa Treatment & Management Introduction
11.8.4 Second Sight Medical Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
11.8.5 Second Sight Medical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinitis Pigmentosa Treatment & Management Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vitamin A
Table 3. Key Players of Docosahexaenoic Acid
Table 4. Key Players of Calcium Channel Blockers
Table 5. Key Players of Gene Therapy
Table 6. Key Players of Retinal Eye Prosthetics
Table 7. Global Retinitis Pigmentosa Treatment & Management Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinitis Pigmentosa Treatment & Management Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinitis Pigmentosa Treatment & Management Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Retinitis Pigmentosa Treatment & Management Market Share by Regions (2016-2021)
Table 11. Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Retinitis Pigmentosa Treatment & Management Market Share by Regions (2022-2027)
Table 13. Retinitis Pigmentosa Treatment & Management Market Trends
Table 14. Retinitis Pigmentosa Treatment & Management Market Drivers
Table 15. Retinitis Pigmentosa Treatment & Management Market Challenges
Table 16. Retinitis Pigmentosa Treatment & Management Market Restraints
Table 17. Global Retinitis Pigmentosa Treatment & Management Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Retinitis Pigmentosa Treatment & Management Market Share by Players (2016-2021)
Table 19. Global Top Retinitis Pigmentosa Treatment & Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa Treatment & Management as of 2020)
Table 20. Ranking of Global Top Retinitis Pigmentosa Treatment & Management Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Retinitis Pigmentosa Treatment & Management Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinitis Pigmentosa Treatment & Management Product Solution and Service
Table 24. Date of Enter into Retinitis Pigmentosa Treatment & Management Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2016-2021)
Table 28. Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Retinitis Pigmentosa Treatment & Management Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2016-2021)
Table 32. Global Retinitis Pigmentosa Treatment & Management Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size by Country (2022-2027) & (US$ Million)
Table 64. ReNeuron Company Details
Table 65. ReNeuron Business Overview
Table 66. ReNeuron Retinitis Pigmentosa Treatment & Management Product
Table 67. ReNeuron Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 68. ReNeuron Recent Development
Table 69. Amarantus BioScience Company Details
Table 70. Amarantus BioScience Business Overview
Table 71. Amarantus BioScience Retinitis Pigmentosa Treatment & Management Product
Table 72. Amarantus BioScience Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 73. Amarantus BioScience Recent Development
Table 74. Ocugen Company Details
Table 75. Ocugen Business Overview
Table 76. Ocugen Retinitis Pigmentosa Treatment & Management Product
Table 77. Ocugen Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 78. Ocugen Recent Development
Table 79. ReGenX Biosciences Company Details
Table 80. ReGenX Biosciences Business Overview
Table 81. ReGenX Biosciences Retinitis Pigmentosa Treatment & Management Product
Table 82. ReGenX Biosciences Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 83. ReGenX Biosciences Recent Development
Table 84. Sucampo Pharmaceuticals Company Details
Table 85. Sucampo Pharmaceuticals Business Overview
Table 86. Sucampo Pharmaceuticals Retinitis Pigmentosa Treatment & Management Product
Table 87. Sucampo Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 88. Sucampo Pharmaceuticals Recent Development
Table 89. Orphagen Pharmaceuticals Company Details
Table 90. Orphagen Pharmaceuticals Business Overview
Table 91. Orphagen Pharmaceuticals Retinitis Pigmentosa Treatment & Management Product
Table 92. Orphagen Pharmaceuticals Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 93. Orphagen Pharmaceuticals Recent Development
Table 94. Okuvision Company Details
Table 95. Okuvision Business Overview
Table 96. Okuvision Retinitis Pigmentosa Treatment & Management Product
Table 97. Okuvision Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 98. Okuvision Recent Development
Table 99. Second Sight Medical Company Details
Table 100. Second Sight Medical Business Overview
Table 101. Second Sight Medical Revenue in Retinitis Pigmentosa Treatment & Management Business (2016-2021) & (US$ Million)
Table 102. Second Sight Medical Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinitis Pigmentosa Treatment & Management Market Share by Type: 2020 VS 2027
Figure 2. Vitamin A Features
Figure 3. Docosahexaenoic Acid Features
Figure 4. Calcium Channel Blockers Features
Figure 5. Gene Therapy Features
Figure 6. Retinal Eye Prosthetics Features
Figure 7. Global Retinitis Pigmentosa Treatment & Management Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Retinitis Pigmentosa Treatment & Management Report Years Considered
Figure 12. Global Retinitis Pigmentosa Treatment & Management Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Retinitis Pigmentosa Treatment & Management Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Retinitis Pigmentosa Treatment & Management Market Share by Regions: 2020 VS 2027
Figure 15. Global Retinitis Pigmentosa Treatment & Management Market Share by Regions (2022-2027)
Figure 16. Global Retinitis Pigmentosa Treatment & Management Market Share by Players in 2020
Figure 17. Global Top Retinitis Pigmentosa Treatment & Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinitis Pigmentosa Treatment & Management as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa Treatment & Management Revenue in 2020
Figure 19. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2016-2021)
Figure 20. Global Retinitis Pigmentosa Treatment & Management Revenue Market Share by Type (2022-2027)
Figure 21. North America Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Retinitis Pigmentosa Treatment & Management Market Share by Type (2016-2027)
Figure 23. North America Retinitis Pigmentosa Treatment & Management Market Share by Application (2016-2027)
Figure 24. North America Retinitis Pigmentosa Treatment & Management Market Share by Country (2016-2027)
Figure 25. United States Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinitis Pigmentosa Treatment & Management Market Share by Type (2016-2027)
Figure 29. Europe Retinitis Pigmentosa Treatment & Management Market Share by Application (2016-2027)
Figure 30. Europe Retinitis Pigmentosa Treatment & Management Market Share by Country (2016-2027)
Figure 31. Germany Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Retinitis Pigmentosa Treatment & Management Market Share by Region (2016-2027)
Figure 41. China Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinitis Pigmentosa Treatment & Management Market Share by Type (2016-2027)
Figure 49. Latin America Retinitis Pigmentosa Treatment & Management Market Share by Application (2016-2027)
Figure 50. Latin America Retinitis Pigmentosa Treatment & Management Market Share by Country (2016-2027)
Figure 51. Mexico Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Retinitis Pigmentosa Treatment & Management Market Share by Country (2016-2027)
Figure 57. Turkey Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Retinitis Pigmentosa Treatment & Management Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. ReNeuron Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 61. Amarantus BioScience Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 62. Ocugen Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 63. ReGenX Biosciences Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 64. Sucampo Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 65. Orphagen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 66. Okuvision Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 67. Second Sight Medical Revenue Growth Rate in Retinitis Pigmentosa Treatment & Management Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---